Skip to main content

Table 6 Relationship between demographic/histopathologic features and pre-NAC tumor SULpeak

From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients

Characteristics Pre-NAC tumor SULpeak P value
Mean SD Range Median
Age (years)      
 ≤ median 54 6.6 4.3 2.5–15 5.2 a0.215
 > median 54 7.5 3.1 2.8–13.7 7.6  
Menopausal status      
 Pre-menopause 6.6 4.3 2.5–15 5.1 a0.341
 Post-menopause 7.3 3.5 2.5–14.1 6.7  
Tumor grade      
 II 6.5 3.5 2.5–14.1 5.4 a0.573
 III 7.6 4.3 2.5–15 6.6  
Tumor molecular type      
 Luminal A 6.1 3.4 2.5–14.1 5.1 b0.549
 Luminal B 7.3 2.6 4.7–12 6.9  
 HER-2 + 6.9 5.6 2.8–15 5.1  
 Basal type 9.2 4.7 4.5–14.4 9.1  
  1. a Mann-Whitney U test
  2. b Kruskal-Wallis test (KW)